ISPO, ALCO & CTLT Class Action Reminders: Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Reminds Investors of Deadlines and to Actively Participate

NEW YORK, NY / ACCESSWIRE / April 11, 2023 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss, you can request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Inspirato Incorporated (NASDAQ:ISPO)
Class Period: May 11, 2022 - December 15, 2022

Deadline: April 17, 2023
For more info:www.bgandg.com/ispo.

The Complaint alleges that the Company made false and misleading statements to the market. Inspirato's financial statements for the quarters ending March 31, 2022 and June 30, 2022 (collectively, the "Non-Reliance Periods") could not be relied upon. The Complaint also alleges that the Company incorrectly applied Accounting Standards Update (ASU) No. 2016-02, Leases (Topic 842) ("ASC 842"), resulting in the unreliability of the Non-Reliance Periods, and based on these facts, the Inspirato's public statements were false and materially misleading throughout the class period.

Alico, Inc. (NASDAQ:ALCO)
Class Period: February 4, 2021 - December 13, 2022

Deadline: April 18, 2023
For more info:www.bgandg.com/alco.

The Complaint alleges that the Company made false and misleading statements to the market, and specifically that Alico: (1) failed to maintain appropriate controls on disclosures and financial reporting; (2) miscalculated its deferred tax liabilities for a multi-year period; and (3) would be forced to restate previously issued financial statements.

Catalent, Inc. (NYSE:CTLT)

Class Period: August 30, 2021 - October 31, 2022

Deadline: April 25, 2023
For more info:www.bgandg.com/ctlt.

The Complaint alleges that statements made by Defendants throughout the Class Period were materially false and misleading when made because they misrepresented or failed to disclose the following adverse facts, which were known to Defendants or recklessly disregarded by them: (1) Catalent materially overstated its revenue and earnings by prematurely recognizing revenue in violation of U.S. Generally Accepted Accounting Principles ("GAAP"); (2) Catalent had material weaknesses in its internal control over financial reporting related to revenue recognition; (3) Catalent falsely represented demand for its products while it knowingly sold more product to its direct customers than could be sold to healthcare providers and end consumers; (4) Catalent disregarded regulatory rules at key production facilities in order to rapidly produce excess inventory that was used to pad the Company's financial results through premature revenue recognition in violation of GAAP and/or stuffing its direct customers with this excess inventory; and (5) as a result of the foregoing, Defendants lacked a reasonable basis for their positive statements about the Company's financial performance, outlook, and regulatory compliance during the Class Period.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Nathanson
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ACCESSWIRE

News network reaching more than 1,500 media outlets in 98 countries. The newest, fastest-growing and most disruptive newswire available today.